A Review on Spinal Muscular Atrophy: Awareness, Knowledge, and Attitudes

Journal of Genetic Counseling

Volumn 25, Issue 5, 2016, Pages 892-900

  Moultrie, Rebecca R ^a   Kish Doto, Julia ^a   Peay, Holly ^a   Lewis, Megan A ^a  

^a RTI INTERNATIONAL   (United States)

Author keywords

Awareness; Beliefs; Carrier screening; Clinicians; Knowledge; Newborn screening; Public; SMA; Spinal muscular atrophy

Indexed keywords

ATTITUDE TO HEALTH; EDUCATION; HEALTH CARE PERSONNEL; HUMAN; INFANT; NEWBORN; NEWBORN SCREENING; PATIENT; PATIENT EDUCATION; PSYCHOLOGY; SPINAL MUSCULAR ATROPHY;

HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HUMANS; INFANT; INFANT, NEWBORN; MUSCULAR ATROPHY, SPINAL; NEONATAL SCREENING; PATIENT EDUCATION AS TOPIC; PATIENTS;

EID: 84963725269     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-016-9955-8     Document Type: Review

References (36)

1. American College of Obstetricians and Gynecologists (ACOG) (2009). Spinal muscular atrophy. ACOG Committee Opinion No. 432. American Journal Of Obstetrics & Gynecology, 113, 1194–1196.
2. Anderton, R. S., & Mastaglia, F. L. (2015). Advances and challenges in developing a therapy for spinal muscular atrophy. Expert Review Of Neurotherapeutics, 15(8), 895–908.
3. Arnold, W. D., Kassar, D., & Kissel, J. T. (2015). Spinal muscular atrophy: diagnosis and management in a new therapeutic era. Muscle And Nerve, 51(157–167), 2015.
4. Bach, J. R., Vega, J., Marjors, J., & Friedman, A. (2003). Spinal muscular atrophy type 1 quality of life. Neuromuscular Disease, 82(2), 137–142.
5. Bailey Jr., D. B., & Gehtland, L. (2015). Newborn screening: evolving challenges in an era of rapid discovery. Jama, 313, 1511–1512.
6. Bailey, D. B., Lewis, M. A., Harris, S. L., Grant, T., Bann, C., Bishop, E., Roche, M., Guarda, S., Barnum, L., Powell, C., & Therrell, B. L. (2013). Design and evaluation of a decision aid for inviting parents to participate in a fragile x newborn screening pilot study. Journal Of Genetic Counseling, 22(1), 108–117.
7. Callum, P., Iger, J., Ray, M., Sims, C. A., & Falk, R. E. (2010). Outcome and experience of implementing spinal muscular atrophy carrier screening on sperm donors. Fertility And Sterility, 94(5), 1912–1914.
8. Carré, A., & Empe, C. (2016). Review of spinal muscular atrophy (SMA) for prenatal and pediatric genetic counselors. Journal Of Genetic Counseling., 25, 32–43.
9. Ciarleglio, L. J., Bennett, R. L., Williamson, J., Mandell, J. B., & Marks, J. H. (2003). Genetic Counseling throughout the Life Cycle. Journal Of Clinical Investigation, 112(9), 1280–1286.
10. Cronister, A. (2015). Genetic counselors and genomics education. Presented at the Inter-Society Coordinating Committee for Practitioner Education in genomics fourth In-Person Meeting, Bethesda, MD. Retrieved from http://www.genome.gov/Pages/Research/ResearchFunding/DGM/Genetic_Counselors_Genomics_Education_052115.pdf.
11. Darras, B. T. (2015). Spinal Muscular Atrophies. Pediatric Clinics Of North America, 62(3), 743–766.
12. De Silva, D., Jayasekera, K. M. S. A. K., Rubasinghe, N. K., & De Silva, D. G. H. (1997). Attitudes towards genetic counseling and testing among medical students and newly qualified doctors. Ceylon Medical Journal, 42(3), 129–132.
13. Eagly, A. H., & Chaiken, S. (1998). Attitude, structure, and function. In D. T. Gilbert, S. T. Fisk, & G. Lindsey (Eds.), Handbook of social psychology (pp. 269–322). New York: McGowan-Hill.
14. Faravelli, I., Nizzarado, M., Comi, G., & Corti, S. (2015). Spinal muscular atrophy[mdash]recent therapeutic advances for an old challenge. Nature Reviews Neurology, 11, 351–359.
15. Fishbein, M., & Ajzen, I. (2010). Predicting and changing behavior: The reasoned action approach. New York, NY: Psychology Press.
16. Gitlin, J. M., Fischbeck, K., Crawford, T. O., Cwik, V., Fleischman, A., Gonye, K., et al. (2010). Carrier testing for spinal muscular atrophy. Genetics In Medicine, 12(10), 621–622.
17. Hendrickson, B. C., Donohoe, C., Arikmaev, V. R., Sugarman, E. A., Labrousse, P., Boguslavskiy, L., et al. (2009). Differences in smn1 allele frequencies among ethnic groups within north america. Journal Of Medical Genetics, 46, 641–644.
18. Kesari, A., Rennert, H., Leonard, D. G. B., Phadke, S., & Mittal, B. (2005). Prenatal diagnosis of spinal muscular atrophy: indian scenario. Prenatal Diagnosis, 25, 641–644.
19. Lewis, M. A., Paquin, R. S., Roche, M. J., Furberg, R. D., Rini, C., Berg, J. S., Powell, C. M., & Bailey, D. B. (2016). parental decisions about genomic sequencing for newborn screening: the nc nexus decision aid. Pediatrics, 137(S1), S16–S23.
20. Lunn, M. R., & Wang, C. H. (2008). Spinal muscular atrophy. The Lancet, 371(9630), 2120–2133.
21. National Institute of Neurological Disease and Stroke (NINDS). (2015). Ninds spinal muscular atrophy information page. Retrieved from http://www.ninds.nih.gov/disorders/sma/sma.htm.
22. Office of Legislative Policy and Analysis (OLPA). (2008). SMA Treatment Acceleration Act, legislative update. Retrieved from http://olpa.od.nih.gov/legislation/110/pendinglegislation/treatment_acceleration.asp.
23. Phan, H. C., Taylor, J. L., Hannon, H., & Howell, R. (2015). Newborn screening for spinal muscular atrophy: anticipating an eminent need. Seminars In Perinatology, 39, 217–229.
24. Pountney, D. (2009). Understanding and managing spinal muscular atrophy. British Journal Of Neuroscience Nursing, 5(7), 326–329.
25. Prior, T. P. (2008). Acmg practice guidelines. carrier screening for spinal muscular atrophy. Genetics In Medicine, 10(11), 840–842.
26. Prior, T. P., Snyder, P. J., Rink, B. D., Pearl, D. K., Pyatt, R. E., Mihal, D. C., et al. (2010). Newborn and carrier screening for spinal muscular atrophy. American Journal Of Medical Genetics Part A, 152A(7), 1608–1616.
27. Prior, T. W., & Russman, B. S. (updated 2013, Original 2000). Spinal muscular atrophy. In R. A. Pagon, M. P. Adam, H. H. Ardinger, S. E. Wallace, A. Amemiya, L. J. H. Bean, et al. (Eds.), GeneReviews (Internet). Seattle: University of Washington, Seattle. Retrieved from http://www.ncbi.nlm.nih.gov/books/NBK1352/.
28. Rimer, B. K., Briss, P. A., Zeller, P. K., Chan, E. C., & Woolf, S. H. (2004). Informed decision making: what is its role in cancer screening? Cancer, 101(5 Suppl), 1214–1228.
29. Rothwell, E., Anderson, R. A., Swoboda, K. J., Stark, L., & Botkin, J. R. (2013). Public attitudes regarding a pilot study of newborn screening for spinal muscular atrophy. American Journal Of Medical Genetics Part A, 161(4), 679–686.
30. Stark, Z., Massie, J., McClaren, B., Ioannou, L., Cousens, N., Lewis, S., et al. (2013). Current practice and attitudes of australian obstetricians toward population-based carrier screening for inherited conditions. Twin Research And Human Genetics, 16(2), 601–607.
31. Sukenik-Halevy, R., Abu leil-Zoabi, U., Peled-Perez, L., Zlotogora, J., & Allon-Shalev, S. (2012). Compliance for genetic screening in the arab population in israel. Israel Medical Association Journal, 14, 538–542.
32. Tsirikos, A. I., & Baker, A. D. L. (2006). Spinal muscular atrophy: classification, aetiology, and treatment of spinal deformity in children and adolescents. Current Orthopaedics, 20, 430–445.
33. Wirth, B. (2000). An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Human Mutation, 15, 228–237.
34. Wirth, B., Barkats, M., Martinat, C., Sendtner, M., & Gillingwater, T. H. (2015). Moving towards treatments for spinal muscular atrophy: hopes and limits. Expert Opinion On Emerging Drugs, 20(3), 353–356.
35. Wood, M. F., Hughes, S. C., Hache, L. P., Naylor, E. W., Abdel-Hamid, H. Z., Barmada, M. M., et al. (2014). Parental attitudes toward newborn screening for duchenne/becker muscular dystrophy and spinal muscular atrophy. Muscle And Nerve, 49(6), 822–828.
36. Zanetta, C., Nizzardo, M., Simone, C., Monguzzi, E., Bresolin, N., Comi, G. P., & Corti, S. (2014). Molecular therapeutic strategies for spinal muscular atrophies: current and future clinical trials. Clinical Therapeutics, 36(1), 128–140.